4 Trends In Biosimilars

Over the next six years, the purchase and production of biosimilar drugs can expect to see high double-digit growth. Are you familiar with the trends driving growth in the hottest market in therapeutic development?

Common Reasons For Trial Rescue

Over a third of trials scheduled to complete in the next year are already failing. What are the warning signs, and how canyou respond to get your trial back on track?

Implementing CDISC Standards

CDISC standards are now mandatory. Your organization can either treat them as another regulatory weight, or use them to mitigate risk, drive down costs, and increase efficiency.

Biorasi is not just a contract research organization. We are Clinical Research Optimized™, which means that we achieve the ideal balance of cost, time and risk management. Through innovative project management processes and technologies, dedication to our sponsors, and a culture of ownership, our team will deliver to you on time, on budget, results every time.

Latest News

The Decision on Timing in the BPCI Act

This week, the path to market for biosimilar developers cleared up just a bit. The Supreme Court made a final decision in the three-year lawsuit between Amgen and Sandoz that sets a precedent regarding the interpretation of some widely-contested language in the BPCI...

read more

Emerging Challenges in Global Clinical Studies

Clinical research is going global. This growth translates to sponsors no longer running separate studies in each and every country they are seeking marketing approval; instead they are opting for large, global studies that have percentages of the required subjects in...

read more